FAP and neoplasm: Key parameters were optimized in FAP-positive U87MG tumor-bearing mice, including the injected mass of 4AH29-TCO (200 μg) and the lag time (8 h) between the injections of 4AH29-TCO and [177Lu]Lu-DOTA-PEG7-tetrazine.